Hearing Loss Prevention

Fennec Pharmaceuticals work in the neuro-ototoxicity space for patients with solid tumors and have partnered with testicular cancer awareness foundation

Fennec is Focused on Helping Cisplatin-Induced Hearing Loss

Cisplatin is a highly effective treatment for testicular cancer. However, one of the side effects is ototoxicity or hearing loss which has a profound impact on quality of life.

Fennec Pharmaceuticals work in the Neuro-ototoxicity space for patients with solid tumors who are treated with cisplatin to reduce the risk of hearing loss.

Learn more About Fennec

NIH Research Studies on testicular cancer

NIH Research Study: Effects of ALA on Cisplatin-induced Ototoxicity

Research studies have suggested that ototoxicity induced by cisplatin is due to an accumulation of reactive oxygen species and oxidative stress. NIH found that Alpha-lipoic acid (ALA) an antioxidant, may have a protective effect on hearing loss induced by cisplatin.

See More NIH Studies